A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease

NCT04269551 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Haemolytic Anaemia

Interventions

DRUG: BIVV020

Sponsor

Bioverativ, a Sanofi company